Brief: MediPharm Labs Gets Milestone Cannabis Drug Licence To Make, Distribute Pharmaceuticals Containing Cannabis
17/02/2021 12:37
Feb 17 (Reuters) - Medipharm Labs Corp LABS.TO :
* MEDIPHARM LABS RECEIVES MILESTONE CANNABIS DRUG LICENCE TO
MANUFACTURE AND DISTRIBUTE PHARMACEUTICALS CONTAINING CANNABIS
INCLUDING NEW DRUGS FOR DISCOVERY TRIALS
Source text for Eikon: ID:nGNXbd5GtC
Further company coverage: LABS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medipharm Labs
See all newsCanada's MediPharm Labs Q2 revenue rises 11% on international growth
Brief: MediPharm Labs Q2 Revenue CAD 10 Million
Canada's MediPharm Labs reports positive Q1 adjusted EBITDA
Canada's MediPharm Labs FY revenue rises 8% on international sales
Brief: Medipharm Labs Reports Full Year & Fourth Quarter 2025 Results With Over 40% Annual Growth In International Medical Revenue